THE INTERIM EXPERTS’ COUNCIL RESOLUTION ON THE EMPA-REG OUTCOME TRIAL ISSUES

THE INTERIM EXPERTS’ COUNCIL RESOLUTION ON THE EMPA-REG OUTCOME TRIAL ISSUES

The interdisciplinary interim experts’ council on March 3, 2016 in Moscow have considered the EMPA-REG OUTCOME trial results and suggested a number of propositions and recommendations on further empagliflozin’s cardiovascular effects investigation and its clinical application in patients with type 2...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. V. Shestakova, S. A. Boytsov, O. M. Drapkina, T. Yu. Demidova, H. Drexel, M. B. Antsiferov, N. A. Petunina, N. A. Chernikova, V. Yu. Kalashnikov, T. P. Bardymova, V. K. Protasov, A. Yu. Babenko, L. A. Ruyatkina, V. V. Klimontov, V. V. Salukhov, V. V. Fadeev, Yu. A. Karpov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-05-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	empagliflozin type 2 diabetes mellitus cardiovascular morbidity and mortality empa-reg outcome trial
Online Access:	https://www.rpcardio.online/jour/article/view/1237
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Resolution of an online meeting of the Volga Federal District experts on the EMPEROR-Reduced trial “A new era in the treatment of patients with HF. From EMPA-REG OUTCOME to EMPEROR-Reduced trial”
by: S. V. Villevalde, et al.
Published: (2021-07-01)

Additional Features in the Treatment of Patients with Chronic Heart Failure. From EMPA-REG OUTCOME Study to EMPEROR-REDUCED Study. Resolution of the On-line Scientific Meeting of Moscow Experts
by: A. Yu. Lebedeva, et al.
Published: (2021-03-01)

Comparative efficacy study of experimental chronic heart failure
by: D. Yu. Ivkin, et al.
Published: (2025-03-01)

Epidemiology and risk factors for cerebral venous sinus thrombosis: insights from leading centres in the i-RegVeD registry, India
by: Sumit Aggarwal, et al.
Published: (2025-07-01)

Assessing ResNeXt and RegNet Models for Diabetic Retinopathy Classification: A Comprehensive Comparative Study
by: Samara Acosta-Jiménez, et al.
Published: (2025-08-01)

Cardiovascular death risk reduction in type 2 diabetes patients with confirmed cardiovascular diseases
by: Е. V. Shlyakhto, et al.
Published: (2018-09-01)

The influence of metformin and empagliflozin administration on gut microbiota in individuals with type 2 diabetes mellitus and hypothyroidism
by: K.A. Moskva, et al.
Published: (2024-06-01)

IN VITRO GENERATION AND CHARACTERIZATION OF HUMAN REGULATORY T-CELLS
by: E. V. Kurganova, et al.
Published: (2014-07-01)

Clinical Efficacy and Safety of Empagliflozin in Patients with Acute Heart Failure from the First Day of Hospitalization
by: D. P. Golubovskaya, et al.
Published: (2023-05-01)

Evaluation of factors influencing adherence to treatment with sodium-glucose cotransporter type 2 inhibitor
by: D. A. Lebedev, et al.
Published: (2020-10-01)

Effects of empagliflozin on exercise tolerance and left ventricular diastolic function in patients with heart failure with preserved ejection fraction and type 2 diabetes: a prospective single-center study
by: A. G. Ovchinnikov, et al.
Published: (2021-02-01)

EVALUAREA EFICACITĂȚII TERAPIEI CU INHIBITORI SGLT2 LA PACIENȚII CU INSUFICIENȚĂ CARDIACĂ CU FRACȚIE DE EJECȚIE PĂSTRATĂ
by: Tatiana Cotonet, et al.
Published: (2025-03-01)

Indonesiaâ€™s Contra-Productive Regulation against the Rights of Unskilled Workers for Balinese in New Zealand
by: Desak Putu Dewi Kasih, et al.
Published: (2023-01-01)

Evaluation of Real-Time PCR Efficiency by the Use of Two Strategies: Standard Curve and Linear Regression
by: Ali Khodadadi, et al.
Published: (2012-03-01)

A Human Engineered Heart Tissue‐Derived Lipotoxic Diabetic Cardiomyopathy Model Revealed Early Benefits of Empagliflozin
by: Lin Cai, et al.
Published: (2025-08-01)

Immune thrombocytopenia: clinical manifestation and therapy response. The interim analysis of Russian register of patients with primary immune thrombocytopenia and literature review
by: I. A. Lisukov, et al.
Published: (2014-07-01)

Empagliflozin Attenuates Neointima Formation After Arterial Injury and Inhibits Smooth Muscle Cell Proliferation and Migration by Suppressing Platelet‐Derived Growth Factor–Related Signaling
by: Gwo‐Jyh Chang, et al.
Published: (2024-11-01)

Interim results on concession agreements for the city of Perm and the Perm region
by: E. V. Rozhkov
Published: (2023-05-01)

Financing national priority projects: interim results and implementation prospects
by: M. A. Valishvili
Published: (2020-11-01)

New possibilities of nephroprotection in patients with chronic heart failure in combination with chronic kidney disease and diabetes mellitus 2 or without it
by: E. V. Kovalenko, et al.
Published: (2022-10-01)

Energy Audit of Agricultural Enterprises: New Approaches and Assessment Criteria (Following the Russian-Finnish Project Interim Outcomes)
by: H. Soininen, et al.
Published: (2020-09-01)

Empagliflozin: a path from glycemic control to reduced cardiovascular mortality and heart failure-related hospitalizations
by: N. R. Khasanov
Published: (2022-02-01)

Fixed trandolapril and verapamil SR combination effectiveness in arterial hypertension patients
by: L. G. Ratova, et al.
Published: (2008-04-01)

Interim Evaluation of the Project P.A.T.H.S.: Findings Based on Different Datasets
by: Daniel T. L. Shek, et al.
Published: (2012-01-01)

CARDIOVASCULAR COMPLICATIONS AND CARBOHYDRATE METABOLISM IN CORONARY SHUNTING “OFF-PUMP” ACCORDING TO THE REGIMEN OF GLUCOSE LOWERING TREATMENT IN ISCHEMIC HEART DISEASE AND DIABETES
by: S. Yu. Borodashkina, et al.
Published: (2016-02-01)

PairReg: A method for enhancing the learning of molecular structure representation in equivariant graph neural networks
by: Zhen Ren, et al.
Published: (2025-01-01)

STRATEGY OF LONG-TERM DEVELOPMENT OF RUSSIAN PENSION SYSTEM: ANALYSIS OF INTERIM RESULTS
by: Pavel A. Kozlov
Published: (2017-09-01)

High‑frequency skin ultrasound possibilities in terms of diagnosing liver cirrhosis
by: D. Yu. Shestakova, et al.
Published: (2024-12-01)

PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC ANALYSIS OF TREATMENT OF ENDOMETRIT IN-HOSPITAL
by: L. Yu. Chernikova, et al.
Published: (2015-12-01)

Interim assessment of the degree of achievement of the planned indicators of the Federal target program «Research and development in priority areas of development of the scientific and technological complex of Russia for 2014–2020»
by: V. B. Mikhailets, et al.
Published: (2019-12-01)

Implementation Guide for Container-Grown Plant Interim Measure
by: Thomas H. Yeager
Published: (2003-04-01)

Correction of thrombohemorrhagic syndrome in patients with widespread soft tissue phlegmon and sepsis
by: E. A. Tseimakh, et al.
Published: (2022-03-01)

RegCGAN: Resampling with Regularized CGAN for Imbalanced Big Data Problem
by: Liwen Xu, et al.
Published: (2025-06-01)

Correspondence distribution over a network in designing public urban passenger transportation tasks
by: A. I. Fadeev, et al.
Published: (2023-07-01)

AEROSOL GENERATION MODES FOR NICOTINECONTAINING PRODUCTS
by: M. V. Shkidyuk, et al.
Published: (2020-11-01)

Systematisation of Scientific approaches to the definition of capital as an Economic and accounting category
by: M. V. Protasov
Published: (2023-10-01)

Modern strategies for the treatment of type 2 diabetes in patients with stable coronary artery disease. Old goals, new opportunities (literature review)
by: S. L. Grishaev, et al.
Published: (2024-03-01)

Role of prokineticins and T-reg cells in obesity-associated metabolic oxidative dysregulation in NAFLD
by: Shyam Prakash, et al.
Published: (2025-08-01)

HiGoReg: A Hierarchical Grouping Strategy for Point Cloud Registration
by: Tengfei Zhou, et al.
Published: (2025-07-01)

Economical analysis of diagnostic study at women with inflammatory diseases of pelvis minor organs
by: L. Yu. Chernikova, et al.
Published: (2004-09-01)